Related Topics:
Facility ID: 27317RRWNT200CO
Facility Name and Address: ARROW INTERNATIONAL INC 312 COMMERCE PL ASHEBORO, NC 27203 Parent Company: TELEFLEX INC Industry: Surgical and Medical Instrument Manufacturing (339112) Chemical: Ethylene oxide Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000075218
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2021 |
Source Reduction: Source Reduction - Ethylene oxide sterilization is required to meet FDA requirements. Arrow International, Inc. implemented the following waste reduction and elimination plan for 2021: 1. Used only 100% ethylene oxide as a sterilant. Ethylene oxide is oxidized, post-process to carbon dioxide and water. 2. Maximized the utilization of the sterilizers by designing product pallet stacking configurations using a software program specifically designed to volumetrically optimize product loading. 3. Product batches were built to completely fill each pallet and a full load of 8 pallets was run through each sterilization cycle to minimize the amount of ethylene oxide used and maximize efficiency. 4. The sterilization processes are designed and validated to use the lowest effective concentration of ethylene oxide necessary to sterilize our products. 5. Standard operating procedures for each sterilization cycle mandate test protocols designed to detect any leaks in the system prior to introduction of ethylene oxide into the sterilization chamber. Ethylene oxide is introduced to each cycle only after the test cycle is successfully complete for every cycle run. If a problem is detected, the cycle is aborted prior to the introduction of ethylene oxide into the chamber, reducing waste and eliminating any potential leakage due to equipment failure. |
||
2020 | Source Reduction - Ethylene oxide sterilization is required to meet FDA requirements. Arrow International, Inc. implemented the following waste reduction and elimination plan for 2020: 1. Used only 100% ethylene oxide as a sterilant. Ethylene oxide is oxidized, post-process to carbon dioxide and water. 2. Maximized the utilization of the sterilizers by designing product pallet stacking configurations using a software program specifically designed to volumetrically optimize product loading. 3. Product batches were built to completely fill each pallet and a full load of 8 pallets was run through each sterilization cycle to minimize the amount of ethylene oxide used and maximize efficiency. 4. The sterilization processes are designed and validated to use the lowest effective concentration of ethylene oxide necessary to sterilize our products. 5. Standard operating procedures for each sterilization cycle mandate test protocols designed to detect any leaks in the system prior to introduction of ethylene oxide into the sterilization chamber. Ethylene oxide is introduced to each cycle only after the test cycle is successfully complete for every cycle run. If a problem is detected, the cycle is aborted prior to the introduction of ethylene oxide into the chamber, reducing waste and eliminating any potential leakage due to equipment failure. | ||
2019 | Source Reduction - Ethylene oxide sterilization is required to meet FDA requirements. Arrow International, Inc. implemented the following waste reduction and elimination plan for 2019: 1. Used only 100% ethylene oxide as a sterilant. Ethylene oxide is oxidized, post-process tocarbon dioxide and water. 2. Maximized the utilization of the sterilizers by designing product pallet stacking configurations using a software program specifically designed to volumetrically optimize product loading. 3. Product batches were built to completelyfill each pallet and a full load of 8 pallets was run through each sterilization cycle to minimize the amount of ethylene oxide used and maximize efficiency. 4. The sterilization processes are designed and validated to use the lowest effective concentration of ethylene oxide necessary to sterilize our products. 5. Standard operating procedures for each sterilization cycle mandate test protocols designed to detect any leaks in the system prior to introduction of ethylene oxide into the sterilization chamber. Ethylene oxide is introduced to each cycle only after the test cycle is successfully complete for every cycle run. If a problem is detected, the cycle is aborted prior to the introduction of ethylene oxide into the chamber, reducing waste and eliminating any potential leakage due to equipment failure. | ||
2018 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - Ethylene oxide sterilization is required to meet FDA requirements. Arrow International, Inc. implemented the following waste reduction and elimination plan for 2018: 1. Used only 100% ethylene oxide as a sterilant. Ethylene oxide is oxidized, post-process to carbon dioxide and water. 2. Maximized the utilization of the sterilizers by designing product pallet stacking configurations using a software program specifically designed to volumetrically optimize product loading. 3. Product batches were built to completely fill each pallet and a full load of 8 pallets was run through each sterilization cycle to minimize the amount of ethylene oxide used and maximize efficiency. 4. The sterilization processes are designed and validated to use the lowest effective concentration of ethylene oxide necessary to sterilize our products. 5. Standard operating procedures for each sterilization cycle mandate test protocols designed to detect any leaks in the system prior to introduction of ethylene oxide into the sterilization chamber. Ethylene oxide is introduced to each cycle only after the test cycle is successfully complete for every cycle run. If a problem is detected, the cycle is aborted prior to the introduction of ethylene oxide into the chamber, reducing waste and eliminating any potential leakage due to equipment failure. |
|
2017 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - Ethylene oxide sterilization is required to meet FDA requirements. Arrow International, Inc. implemented the following waste reduction and elimination plan for 2017: 1.Used only 100% ethylene oxide as a sterilant. Ethylene oxide is oxidized, post-process to carbon dioxide and water. 2. Maximized the utilization of the sterilizers by designing product pallet stacking configurations using a software program specifically designed to volumetrically optimize product loading. 3. Product batches were built to completely fill each pallet and a full load of 8 pallets was run through each sterilization cycle to minimize the amount of ethylene oxide used and maximize efficiency. 4. The sterilization processes are designed and validated to use the lowest effective concentration of ethylene oxide necessary to sterilize our products. 5. Standard operating procedures for each sterilization cycle mandate test protocols designed to detect any leaks in the system prior to introduction of ethylene oxide into the sterilization chamber. Ethylene oxide is introduced to each cycle only after the test cycle is successfully complete for every cycle run. If a problem is detected, the cycle is aborted prior to the introduction of ethylene oxide into the chamber, reducing waste and eliminating any potential leakage due to equipment failure. |
|
2016 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - Ethylene oxide sterilization required to meet FDA requirements. Arrow International, Inc. implemented the following waste reduction and elimination plan for 2016: 1. Used only 100% ethylene oxide as a sterilant. Ethylene oxide is oxidized, post-process to carbon dioxide and water. 2. Maximized the utilization of the sterilizers by designing product pallet stacking configurations using a software program specifically designed to volumetrically optimize product loading. 3. Product batches were built to completely fill each pallet and a full load of 8 pallets is run through each sterilization cycle to minimize the amount of ethylene oxide used and maximize efficiency. 4. The sterilization processes are designed and validated to use the lowest effective concentration of ethylene oxide necessary to sterilize our products. 5. Standard operating procedures for each sterilization cycle mandate test protocols designed to detect any leaks in the system prior to introduction of ethylene oxide into the sterilization chamber. Ethylene oxide is introduced to each cycle only after the test cycle is successfully complete for every cycle run. If a problem is detected, the cycle is aborted prior to the introduction of ethylene oxide into the chamber, reducing waste and eliminating any potential leakage due to equipment failure. |
|
1995 |
Source Reduction:: W58: Other process modifications
|
Methods to Identify SR Opportunities: T11: Other
|